文献速递主动脉疾病内脏/肾动脉与血管畸形

开放 paravisceral 主动脉瘤修复中同期肾动脉重建的结局

Outcomes of concomitant renal reconstruction during open paravisceral aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2017-06-22

该单中心回顾性研究纳入2010至2015年125例开放腹主动脉瘤修复患者,其中57例(46%)行76次肾动脉重建。肾重建组并发症率显著升高,透析需求达33% vs 无重建组16%(P=.01);急诊手术是30天死亡的最强预测因素(24% vs 择期4%,P<.001)。

要点

  • 肾动脉重建与透析需求增加独立相关(33% vs 16%,P=.01)。
  • 肾动脉再植入(伴或不伴内膜剥脱)较单纯内膜剥脱增加透析和肾丢失风险。
  • 急诊/紧急手术是30天死亡的最强预测因素(24% vs 4%)。

核心结论

  • 开放 paravisceral 主动脉瘤修复同期行肾动脉重建与并发症率升高相关,主要由再植入血管闭塞和透析需求增加驱动。
  • 非择期手术是早期死亡或不良结局的最大决定因素。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010至2015年开放IV型胸腹、肾上及肾旁主动脉瘤修复患者125例。
  • 57例(46%)行76次肾动脉重建(38例单侧,19例双侧)。

主要发现

  • 总体并发症率50%,肾重建组显著升高,主要因透析需求33% vs 无重建组16%(P=.01)。
  • 总体30天死亡率9%,组间无差异;急诊/紧急手术30天死亡率24% vs 择期4%(P<.001)。
  • 肾重建(P=.01)和急诊/紧急状态(P=.04)预测透析需求;肾丢失与透析需求增加无关(P=.2)。
  • 再植入伴或不伴内膜剥脱较单纯内膜剥脱增加透析需求(P=.005)和肾丢失(P=.04)风险。
  • 晚期随访平均肌酐1.4 mg/dL(术前1.3 mg/dL),肾重建组1.5 mg/dL vs 无重建组1.4 mg/dL,无统计学差异。

关键数值与推荐

  • 肾动脉重建技术包括外翻式内膜剥脱(n=21)、经主动脉支架(n=2)、再植入伴内膜剥脱(n=25)或不伴(n=17)、旁路(n=4)和结扎(n=7)。
  • 肾丢失定义为动脉闭塞。
  • 平均动脉瘤直径6.4 cm,23%(n=29)为急诊/紧急手术,20%(n=25)有既往开放或腔内修复史。

临床怎么用

  • 开放 paravisceral 主动脉瘤修复中需行肾动脉重建时,应充分评估透析风险,尤其再植入技术。
  • 急诊/紧急手术患者预后显著更差,应优化围术期管理。
  • 肾重建组与非重建组晚期肾功能(肌酐)无显著差异,但需警惕再植入血管闭塞。

局限性

  • 单中心回顾性研究,样本量有限(125例),可能存在选择偏倚。
  • 平均随访26个月,定向影像随访平均18个月,远期结局数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to review the outcomes of renal artery revascularizations during open aortic aneurysm repair. METHODS: Open abdominal aneurysm repairs performed from 2010 to 2015 at a single institution were reviewed, including type IV thoracoabdominal, suprarenal, and juxtarenal aneurysms. Direct renal reconstruction techniques included eversion endarterectomy, bypass, and vessel reimplantation based on the patient's anatomy. Renal loss was defined by artery occlusion. RESULTS: The study included 125 patients; of these, 57 patients (46%) had 76 renal reconstructions (38 single, 19 bilateral) performed. Interventions included endarterectomy (n = 21), transaortic stenting (n = 2), reimplantation with (n = 25) or without (n = 17) endarterectomy, bypass (n = 4), and ligation (n = 7). Mean aneurysm size was 6.4 cm, with 23% (n = 29) urgent/emergent operations and 20% (n = 25) having had a prior open or endovascular repair. Overall complication rate was 50%, with significant increase among the group requiring renal intervention, primarily accounted for by a 33% early or late dialysis requirement compared with 16% in patients with no renal revascularization (P = .01). Overall 30-day mortality was 9%, with no difference between groups. Urgent/emergent operation (P < .001) was associated with increased 30-day mortality (24% vs 4% elective procedures), but prior open or endovascular repair (P = .4) was not. Mean follow-up was 26 months, with directed imaging out to a mean of 18 months. Renal intervention (P = .01) and urgent/emergent status (P = .04) were predictive of dialysis requirement; however, among those undergoing intervention, renal loss was not associated with an increase in dialysis requirement (P = .2). Of the directed intervention techniques, renal reimplantation with or without endarterectomy was associated with increased risk of dialysis requirement (P = .005) and renal loss (P = .04) relative to endarterectomy alone. Mean creatinine concentration on late follow-up was 1.4 mg/dL (from 1.3 mg/dL preoperatively) and was not statistically significantly different between those undergoing renal intervention (1.5 mg/dL) and those who did not (1.4 mg/dL). CONCLUSIONS: Renal artery reconstruction at the time of open repair of paravisceral aneurysms is associated with an increased complication rate, primarily driven by occlusion of reimplanted vessels and increased dialysis requirement. As reported by others, nonelective presentation is the greatest determinant of early death or adverse outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wooster M, Back M, Patel S, et al. Outcomes of concomitant renal reconstruction during open paravisceral aortic aneurysm repair. J Vasc Surg. 2017. PMID: 28648481. doi:10.1016/j.jvs.2017.04.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。